Moderna Easily Outpaces Giant Rivals in Stock Market
Sometimes its good to be the underdog. Just ask Moderna stockholders. With federal health regulators approving COVID-19 boosters for the biotech firm, its shares continue to outstrip other vaccine makers.
Moderna stock was up was up 1.6% in early trading…
